Location
Areas of Expertise
About Me
Dr. Dean Hainsworth is a retina specialist at MU Health Care who treats a range of vitreoretinal conditions, including diabetic retinopathy, macular degeneration, retinal detachment, and histoplasmosis. He serves as the Vitreoretinal Service Chief at the Harry S. Truman Memorial Veterans' Hospital and is a Professor of Ophthalmology.
As Director of the Clinical Research Center, Dr. Hainsworth manages clinical trials focused on diabetic retinopathy and macular degeneration. He is the Principal Investigator for the EDIC clinical trial, the longest running study in the U.S. examining the clinical course of patients with type 1 diabetes. His research also includes developing a urine sensor for detecting diabetic retinopathy, which may help reduce the need for yearly screening eye exams.
Dr. Hainsworth is board certified by the American Board of Ophthalmology and holds the George L. and Melna A. Bolm Distinguished Faculty Scholar in Ophthalmology.
Training
Vitreo - Retinal Disease
Duke University Medical Center
Fellowship
Internal Medicine
University of Kentucky
ResidencyOphthalmology
University of Kentucky
Residency
Awards & Honors
George L. and Melna A. Bolm Distinguished Faculty Scholar in Ophthalmology
Publications & Press
Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes
NEJM•2017Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients with Type 1 Diabetes: 18 Years of Follow-Up in the DCCT/EDIC
Diabetes•2015Surgical management of rhegmatogenous retinal detachment: a meta-analysis of randomized controlled trials
Ophthalmology•2013Comparison of Digital and Film Grading of Diabetic Retinopathy Severity in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
Arch Ophthalmol•2011Effect of Prior Intensive Therapy in Type 1 Diabetes on 10-Year Progression of Retinopathy in the DCCT-EDIC: Comparison of Adults and Adolescents
Diabetes•2010Funduscopic and Angiographic Appearance in the Neuronal Ceroid Lipofuscinoses
Retina•2009Prolonged Effect of Intensive Therapy on the Risk of Retinopathy Complications in Patients with Type 1 Diabetes: 10 years after the DCCT
Arch Ophthalmol•2008
Certifications & Licensure
- Licensed In
- MO
- License Numbers
- 110608
